{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:54:36Z","timestamp":1787644476822,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"DOI":"10.1186\/s41927-025-00584-x","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:24:13Z","timestamp":1762874653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Machine learning for predicting treatment response to biologic and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a scoping review"],"prefix":"10.1186","volume":"9","author":[{"given":"Ehiremen Bennard","family":"Eriakha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"584_CR1","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001.","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"584_CR2","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1316\u201322.","journal-title":"Ann Rheum Dis"},{"issue":"10055","key":"584_CR3","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023\u201338.","journal-title":"Lancet"},{"issue":"10086","key":"584_CR4","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017;389(10086):2338\u201348.","journal-title":"Lancet"},{"issue":"4","key":"584_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00296-025-05825-3","volume":"45","author":"D Benavent","year":"2025","unstructured":"Benavent D, Carmona L, Garc\u00eda Llorente JF, Montoro M, Ramirez S, Ot\u00f3n T, et al. Artificial intelligence to predict treatment response in rheumatoid arthritis and spondyloarthritis: a scoping review. Rheumatol Int. 2025;45(4):91.","journal-title":"Rheumatol Int"},{"issue":"14","key":"584_CR6","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJMra1814259","volume":"380","author":"A Rajkomar","year":"2019","unstructured":"Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019;380(14):1347\u201358.","journal-title":"N Engl J Med"},{"key":"584_CR7","doi-asserted-by":"publisher","first-page":"152501","DOI":"10.1016\/j.semarthrit.2024.152501","volume":"68","author":"C Mendoza-Pinto","year":"2024","unstructured":"Mendoza-Pinto C, S\u00e1nchez-Tecuatl M, Berra-Romani R, Maya-Castro ID, Etchegaray-Morales I, Mungu\u00eda-Realpozo P, et al. Machine learning in the prediction of treatment response in rheumatoid arthritis: a systematic review. Semin Arthritis Rheum. 2024;68:152501.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"584_CR8","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s40744-022-00475-4","volume":"9","author":"S Momtazmanesh","year":"2022","unstructured":"Momtazmanesh S, Nowroozi A, Rezaei N. Artificial intelligence in rheumatoid arthritis: current status and future perspectives: a state-of-the-art review. Rheumatol Ther. 2022;9(5):1249\u2013304.","journal-title":"Rheumatol Ther"},{"issue":"5","key":"584_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336\u201341.","journal-title":"Int J Surg"},{"issue":"10","key":"584_CR10","doi-asserted-by":"publisher","first-page":"e1001744","DOI":"10.1371\/journal.pmed.1001744","volume":"11","author":"KGM Moons","year":"2014","unstructured":"Moons KGM, de Groot JAH, Bouwmeester W, Vergouwe Y, Mallett S, Altman DG, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med. 2014;11(10):e1001744.","journal-title":"PLoS Med"},{"issue":"1","key":"584_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12874-020-0897-3","volume":"20","author":"H Harrison","year":"2020","unstructured":"Harrison H, Griffin SJ, Kuhn I, Usher-Smith JA. Software tools to support title and abstract screening for systematic reviews in healthcare: an evaluation. BMC Med Res Methodol. 2020;20(1):7.","journal-title":"BMC Med Res Methodol"},{"key":"584_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-3-031-35314-7_2","volume-title":"Artificial intelligence application in networks and systems","author":"G Naidu","year":"2023","unstructured":"Naidu G, Zuva T, Sibanda EM. A review of evaluation metrics in machine learning algorithms. In: Silhavy R, Silhavy P, editors. Artificial intelligence application in networks and systems. Cham: Springer; 2023. pp. 15\u201325."},{"key":"584_CR13","unstructured":"Eklund A, Trimble J, beeswarm. The Bee Swarm Plot, an Alternative to Stripchart [Internet]. 2021 [cited 2025 Apr 23]. Available from: https:\/\/cran.r-project.org\/web\/packages\/beeswarm\/index.html"},{"issue":"4","key":"584_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","volume":"158","author":"JA van der Hayden","year":"2013","unstructured":"van der Hayden JA, Cartwright JL, C\u00f4t\u00e9 P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158(4):280\u20136.","journal-title":"Ann Intern Med"},{"key":"584_CR15","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, van Calster B, et al. TRIPOD + AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378.","journal-title":"BMJ"},{"issue":"7","key":"584_CR16","doi-asserted-by":"publisher","first-page":"e048008","DOI":"10.1136\/bmjopen-2020-048008","volume":"11","author":"GS Collins","year":"2021","unstructured":"Collins GS, Dhiman P, Andaur Navarro CL, Ma J, Hooft L, Reitsma JB, et al. Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence. BMJ Open. 2021;11(7):e048008.","journal-title":"BMJ Open"},{"issue":"1","key":"584_CR17","doi-asserted-by":"publisher","first-page":"20169","DOI":"10.1038\/s41598-021-99625-x","volume":"11","author":"W Kim","year":"2021","unstructured":"Kim W, Kim TH, Oh SJ, Kim HJ, Kim JH, Kim HA, et al. Association of TLR9 gene polymorphisms with remission in patients with rheumatoid arthritis receiving TNF-\u03b1 inhibitors and development of machine learning models. Sci Rep. 2021;11(1):20169.","journal-title":"Sci Rep"},{"key":"584_CR18","doi-asserted-by":"publisher","first-page":"109094","DOI":"10.1016\/j.intimp.2022.109094","volume":"111","author":"W Kim","year":"2022","unstructured":"Kim W, Jin Oh S, Thi Trinh N, Yeon Gil J, Ah Choi I, Hyoun Kim J, et al. Effects of RETN polymorphisms on treatment response in rheumatoid arthritis patients receiving TNF-\u03b1 inhibitors and utilization of machine-learning algorithms. Int Immunopharmacol. 2022;111:109094.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"584_CR19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s12026-023-09382-4","volume":"71","author":"W Kim","year":"2023","unstructured":"Kim W, Yeon HR, Kim JH, Kim JH, Kim JH, Kim HA, et al. Association between SYVN1 and SEL1 genetic polymorphisms and remission in rheumatoid arthritis patients treated with TNF-\u03b1 inhibitors: a machine learning approach. Immunol Res. 2023;71(5):709\u201316.","journal-title":"Immunol Res"},{"issue":"1","key":"584_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13075-021-02567-y","volume":"23","author":"BS Koo","year":"2021","unstructured":"Koo BS, Eun S, Shin K, Yoon H, Hong C, Kim DH, et al. Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics. Arthritis Res Ther. 2021;23(1):178.","journal-title":"Arthritis Res Ther"},{"key":"584_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13075-022-02918-3","volume":"24","author":"BS Koo","year":"2022","unstructured":"Koo BS, Eun S, Shin K, Hong S, Kim YG, Lee CK, et al. Differences in trajectory of disease activity according to biologic and targeted synthetic disease-modifying anti-rheumatic drug treatment in patients with rheumatoid arthritis. Arthritis Res Ther. 2022;24:233.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"584_CR22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13075-021-02635-3","volume":"23","author":"S Lee","year":"2021","unstructured":"Lee S, Kang S, Eun Y, Won HH, Kim H, Lee J, et al. Machine learning-based prediction model for responses of bDMARDs in patients with rheumatoid arthritis and ankylosing spondylitis. Arthritis Res Ther. 2021;23(1):254.","journal-title":"Arthritis Res Ther"},{"key":"584_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2019.03.002","volume":"202","author":"KJ Kim","year":"2019","unstructured":"Kim KJ, Kim M, Adamopoulos IE, Tagkopoulos I. Compendium of synovial signatures identifies pathologic characteristics for predicting treatment response in rheumatoid arthritis patients. Clin Immunol. 2019;202:1\u201310.","journal-title":"Clin Immunol"},{"issue":"12","key":"584_CR24","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/acr2.11499","volume":"4","author":"JR Curtis","year":"2022","unstructured":"Curtis JR, Su Y, Black S, Xu S, Langholff W, Bingham CO, et al. Machine learning applied to patient-reported outcomes to classify physician-derived measures of rheumatoid arthritis disease activity. ACR Open Rheumatol. 2022;4(12):995\u20131003.","journal-title":"ACR Open Rheumatol"},{"issue":"4","key":"584_CR25","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s40744-023-00568-8","volume":"10","author":"JR Curtis","year":"2023","unstructured":"Curtis JR, Yun H, Chen L, Ford SS, van Hoogstraten H, Fiore S, et al. Real-world sarilumab use and rule testing to predict treatment response in patients with rheumatoid arthritis: findings from the RISE registry. Rheumatol Ther. 2023;10(4):1055\u201372.","journal-title":"Rheumatol Ther"},{"issue":"9","key":"584_CR26","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3899\/jrheum.201626","volume":"48","author":"FD Johansson","year":"2021","unstructured":"Johansson FD, Collins JE, Yau V, Guan H, Kim SC, Losina E, et al. Predicting response to Tocilizumab monotherapy in rheumatoid arthritis: a real-world data analysis using machine learning. J Rheumatol. 2021;48(9):1364\u201370.","journal-title":"J Rheumatol"},{"issue":"12","key":"584_CR27","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/art.41056","volume":"71","author":"Y Guan","year":"2019","unstructured":"Guan Y, Zhang H, Quang D, Wang Z, Parker SCJ, Pappas DA, et al. Machine learning to predict anti-tumor necrosis factor drug responses of rheumatoid arthritis patients by integrating clinical and genetic markers. Arthritis Rheumatol. 2019;71(12):1987\u201396.","journal-title":"Arthritis Rheumatol"},{"key":"584_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13075-020-02408-4","volume":"23","author":"DH Solomon","year":"2021","unstructured":"Solomon DH, Xu C, Collins J, Kim SC, Losina E, Yau V, et al. The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of Tocilizumab monotherapy. Arthritis Res Ther. 2021;23:26.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"584_CR29","doi-asserted-by":"publisher","first-page":"e002442","DOI":"10.1136\/rmdopen-2022-002442","volume":"8","author":"V Bouget","year":"2022","unstructured":"Bouget V, Duquesne J, Hassler S, Courn\u00e8de PH, Fautrel B, Guillemin F, et al. Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts. RMD Open. 2022;8(2):e002442.","journal-title":"RMD Open"},{"issue":"1","key":"584_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13075-021-02439-5","volume":"23","author":"A Vodencarevic","year":"2021","unstructured":"Vodencarevic A, Tascilar K, Hartmann F, Reiser M, Hueber AJ, Haschka J, et al. Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugs. Arthritis Res Ther. 2021;23(1):67.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"584_CR31","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s40744-023-00597-3","volume":"10","author":"R Alten","year":"2023","unstructured":"Alten R, Burmester GR, Matucci-Cerinic M, Salmon JH, \u00d6st\u00f6r A, Ng KJ, et al. Comparative effectiveness, time to discontinuation, and patient-reported outcomes with baricitinib in rheumatoid arthritis: 2-year data from the multinational, prospective observational RA-BE-REAL study in European patients. Rheumatol Ther. 2023;10(6):1575\u201395.","journal-title":"Rheumatol Ther"},{"key":"584_CR32","doi-asserted-by":"publisher","first-page":"631662","DOI":"10.3389\/fimmu.2021.631662","volume":"12","author":"M Luque-T\u00e9var","year":"2021","unstructured":"Luque-T\u00e9var M, Perez-Sanchez C, Pati\u00f1o-Trives AM, Barbarroja N, de la Arias I, Abalos-Aguilera MC, et al. Integrative clinical, molecular, and computational analysis identify novel biomarkers and differential profiles of anti-TNF response in rheumatoid arthritis. Front Immunol. 2021;12:631662.","journal-title":"Front Immunol"},{"issue":"3","key":"584_CR33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s40744-024-00668-z","volume":"11","author":"K Sonomoto","year":"2024","unstructured":"Sonomoto K, Fujino Y, Tanaka H, Nagayasu A, Nakayamada S, Tanaka Y. A machine learning approach for prediction of CDAI remission with TNF inhibitors: a concept of precision medicine from the FIRST registry. Rheumatol Ther. 2024;11(3):709\u201336.","journal-title":"Rheumatol Ther"},{"issue":"6","key":"584_CR34","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3109\/14397595.2016.1168536","volume":"26","author":"F Miyoshi","year":"2016","unstructured":"Miyoshi F, Honne K, Minota S, Okada M, Ogawa N, Mimura T. A novel method predicting clinical response using only background clinical data in RA patients before treatment with Infliximab. Mod Rheumatol. 2016;26(6):813\u20136.","journal-title":"Mod Rheumatol"},{"issue":"4","key":"584_CR35","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/mr\/roac086","volume":"33","author":"MRA Shipa","year":"2023","unstructured":"Shipa MRA, Di Cicco M, Balogh E, Nitu NA, Mainuddin MD, Bhadauria N, et al. Drug-survival profiling of second-line biologic therapy in rheumatoid arthritis: choice of another tumour necrosis factor inhibitor or a biologic of different mode of action? Mod Rheumatol. 2023;33(4):700\u20137.","journal-title":"Mod Rheumatol"},{"key":"584_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13075-024-03277-x","volume":"26","author":"D Ukalovic","year":"2024","unstructured":"Ukalovic D, Leeb BF, Rintelen B, Eichbauer-Sturm G, Spellitz P, Puchner R, et al. Prediction of ineffectiveness of biological drugs using machine learning and explainable AI methods: data from the Austrian biological registry BioReg. Arthritis Res Ther. 2024;26:44.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"584_CR37","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/rheumatology\/keab521","volume":"61","author":"N Yoosuf","year":"2022","unstructured":"Yoosuf N, Maciejewski M, Ziemek D, Jelinsky SA, Folkersen L, M\u00fcller M, et al. Early prediction of clinical response to anti-TNF treatment using multi-omics and machine learning in rheumatoid arthritis. Rheumatology (Oxford). 2022;61(4):1680\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"584_CR38","doi-asserted-by":"publisher","first-page":"1303231","DOI":"10.3389\/fimmu.2023.1303231","volume":"14","author":"I Hageman","year":"2023","unstructured":"Hageman I, Mol F, Atiqi S, Joustra V, Sengul H, Henneman P, et al. Novel DNA methylome biomarkers associated with adalimumab response in rheumatoid arthritis patients. Front Immunol. 2023;14:1303231.","journal-title":"Front Immunol"},{"issue":"2","key":"584_CR39","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/art.41516","volume":"73","author":"W Tao","year":"2021","unstructured":"Tao W, Concepcion AN, Vianen M, Marijnissen ACA, Lafeber FPGJ, Radstake TRDJ, et al. Multiomics and machine learning accurately predict clinical response to adalimumab and etanercept therapy in patients with rheumatoid arthritis. Arthritis Rheumatol. 2021;73(2):212\u201322.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"584_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/acr2.11101","volume":"2","author":"JE Collins","year":"2020","unstructured":"Collins JE, Johansson FD, Gale S, Kim S, Shrestha S, Sontag D, et al. Predicting remission among patients with rheumatoid arthritis starting Tocilizumab monotherapy: model derivation and remission score development. ACR Open Rheumatol. 2020;2(2):65\u201373.","journal-title":"ACR Open Rheumatol"},{"issue":"8","key":"584_CR41","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.cell.2023.01.035","volume":"186","author":"K Swanson","year":"2023","unstructured":"Swanson K, Wu E, Zhang A, Alizadeh AA, Zou J. From patterns to patients: advances in clinical machine learning for cancer diagnosis, prognosis, and treatment. Cell. 2023;186(8):1772\u201391.","journal-title":"Cell"},{"issue":"1","key":"584_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41698-019-0106-1","volume":"4","author":"G Adam","year":"2020","unstructured":"Adam G, Ramp\u00e1\u0161ek L, Safikhani Z, Smirnov P, Haibe-Kains B, Goldenberg A. Machine learning approaches to drug response prediction: challenges and recent progress. NPJ Precis Oncol. 2020;4(1):1\u201310.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"584_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41698-018-0074-x","volume":"3","author":"H Nasief","year":"2019","unstructured":"Nasief H, Zheng C, Schott D, Hall W, Tsai S, Erickson B, et al. A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer. NPJ Precis Oncol. 2019;3(1):1\u201310.","journal-title":"NPJ Precis Oncol"},{"key":"584_CR44","doi-asserted-by":"crossref","unstructured":"Wu W, Zhang W, Sadiq S, Tse G, Khalid SG, Fan Y, et al. Chapter 27 \u2013 An up-to-date systematic review on machine learning approaches for predicting treatment response in diabetes. In: Dash S, Pani SK, Susilo W, Yung BBM, Tse G, editors. Internet of Things and Machine Learning for Type I and Type II Diabetes. Elsevier; 2024. p. 397\u2013409. [cited 2025 May 31]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780323956864000277","DOI":"10.1016\/B978-0-323-95686-4.00027-7"},{"issue":"10","key":"584_CR45","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.2337\/dbi20-0002","volume":"69","author":"JM Dennis","year":"2020","unstructured":"Dennis JM. Precision medicine in type 2 diabetes: using individualized prediction models to optimize selection of treatment. Diabetes. 2020;69(10):2075\u201385.","journal-title":"Diabetes"},{"key":"584_CR46","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2147\/CLEP.S505966","volume":"17","author":"G Chandra","year":"2025","unstructured":"Chandra G, Lavikainen P, Siirtola P, Tamminen S, Ihalapathirana A, Laatikainen T, et al. Explainable prediction of long-term glycated hemoglobin response change in Finnish patients with type 2 diabetes following drug initiation using evidence-based machine learning approaches. Clin Epidemiol. 2025;17:225\u201340.","journal-title":"Clin Epidemiol"},{"key":"584_CR47","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jad.2023.02.007","volume":"327","author":"N Rost","year":"2023","unstructured":"Rost N, Dwyer DB, Gaffron S, Rechberger S, Maier D, Binder EB, et al. Multimodal predictions of treatment outcome in major depression: a comparison of data-driven predictors with importance ratings by clinicians. J Affect Disord. 2023;327:330\u20139.","journal-title":"J Affect Disord"},{"key":"584_CR48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jclinepi.2015.04.005","volume":"69","author":"EW Steyerberg","year":"2016","unstructured":"Steyerberg EW, Harrell FE. Prediction models need appropriate internal, internal-external, and external validation. J Clin Epidemiol. 2016;69:245\u20137.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"584_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/ckj\/sfaa188","volume":"14","author":"CL Ramspek","year":"2020","unstructured":"Ramspek CL, Jager KJ, Dekker FW, Zoccali C, van Diepen M. External validation of prognostic models: what, why, how, when and where? Clin Kidney J. 2020;14(1):49\u201358.","journal-title":"Clin Kidney J"},{"issue":"12","key":"584_CR50","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.autrev.2017.10.002","volume":"16","author":"EG Favalli","year":"2017","unstructured":"Favalli EG, Raimondo MG, Becciolini A, Crotti C, Biggioggero M, Caporali R. The management of first-line biologic therapy failures in rheumatoid arthritis: current practice and future perspectives. Autoimmun Rev. 2017;16(12):1185\u201395.","journal-title":"Autoimmun Rev"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00584-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-025-00584-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00584-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T16:05:18Z","timestamp":1762877118000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-025-00584-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1186\/s41927-025-00584-x","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}